tiprankstipranks
Advertisement
Advertisement

HK:9606 Stock Latest News

Duality Biotherapeutics Sets 2026 AGM With Capital Mandates on Agenda
Company AnnouncementsDuality Biotherapeutics Sets 2026 AGM With Capital Mandates on Agenda
2d ago
9606
Duality Biotherapeutics Launches US$40 Million Buyback as Chairman Plans Stake Increase
PremiumCompany Announcements
Duality Biotherapeutics Launches US$40 Million Buyback as Chairman Plans Stake Increase
18d ago
9606
Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC
PremiumCompany Announcements
Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC
25d ago
9606
Duality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
PremiumCompany Announcements
Duality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
1M ago
9606
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
PremiumCompany Announcements
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
2M ago
9606
Duality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
PremiumCompany AnnouncementsDuality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
2M ago
9606
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
Premium
Company Announcements
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
2M ago
9606
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
Premium
Company Announcements
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
2M ago
9606
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
PremiumRatings
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
2M ago
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
PremiumCompany Announcements
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
3M ago
9606
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
PremiumCompany Announcements
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
3M ago
9606
Duality Biotherapeutics Details Board and Committee Structure
PremiumCompany Announcements
Duality Biotherapeutics Details Board and Committee Structure
3M ago
9606
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
PremiumCompany AnnouncementsDuality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
3M ago
9606
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
Premium
Company Announcements
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
3M ago
9606
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
Premium
Company Announcements
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
5M ago
9606
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
PremiumCompany Announcements
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
6M ago
9606
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
PremiumCompany Announcements
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
6M ago
9606
Duality Biotherapeutics Announces Extraordinary General Meeting
PremiumCompany Announcements
Duality Biotherapeutics Announces Extraordinary General Meeting
6M ago
9606
Duality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
PremiumCompany Announcements
Duality Biotherapeutics Plans RMB Share Listing on Shanghai’s Sci-Tech Board
8M ago
9606
Duality Biotherapeutics Gains Inclusion in Key Stock Indices
PremiumCompany AnnouncementsDuality Biotherapeutics Gains Inclusion in Key Stock Indices
9M ago
9606
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
Premium
Company Announcements
Duality Biotherapeutics Achieves Key Milestone in Cancer Drug Trial
9M ago
9606
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
Premium
Ratings
Duality Biotherapeutics, Inc.: Strong Growth Potential and Innovation Drive Buy Rating
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >